Vicens Quentin, Westhof Eric
Institut de Biologie Moléculaire et Cellulaire du CNRS, Modélisation et simulations des Acides Nucléiques, UPR 9002, Université Louis Pasteur, 15 rue René Descartes, 67084 Strasbourg Cedex, France.
Biopolymers. 2003 Sep;70(1):42-57. doi: 10.1002/bip.10414.
The potential of RNA molecules to be used as therapeutic targets by small inhibitors is now well established. In this fascinating wide-open field, aminoglycoside antibiotics constitute the most studied family of RNA binding drugs. Within the last three years, several x-ray crystal structures were solved for aminoglycosides complexed to one of their main natural targets in the bacterial cell, the decoding aminoacyl-tRNA site (A site). Other crystallographic structures have revealed the binding modes of aminoglycosides to the three existing types of resistance-associated enzymes. The present review summarizes the various aspects of the molecular recognition of aminoglycosides by these natural RNA or protein receptors. The analysis and the comparisons of the detailed interactions offer insights that are helpful in designing new generations of antibiotics.
RNA分子被小分子抑制剂用作治疗靶点的潜力现已得到充分证实。在这个引人入胜的广阔领域中,氨基糖苷类抗生素是研究最多的一类RNA结合药物。在过去三年里,人们解析了几种氨基糖苷类抗生素与它们在细菌细胞中的主要天然靶点之一——解码氨酰tRNA位点(A位点)——形成的复合物的X射线晶体结构。其他晶体结构揭示了氨基糖苷类抗生素与三种现有类型的耐药相关酶的结合模式。本综述总结了这些天然RNA或蛋白质受体对氨基糖苷类抗生素分子识别的各个方面。对详细相互作用的分析和比较提供了有助于设计新一代抗生素的见解。